ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Xin Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3811-9480; OpenAlex author ID A5100620051. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine. Co-author DOI 10.1039/d5md00488h ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chen Wang · 1 shared paper, 2025 · strength 0.22
- Paper Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses… DOI 10.1039/d5md00488h ↗
Haiyan Xu · 1 shared paper, 2025 · strength 0.22
- Paper Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses… DOI 10.1039/d5md00488h ↗
Ke Zhu · 1 shared paper, 2025 · strength 0.22
- Paper Development of a CXCR4 antagonistic peptide, P12, to suppress pancreatic cancer progress via enhancing T cell responses… DOI 10.1039/d5md00488h ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.